Uniphar Medtech announced that six of its established healthcare businesses have united under a single brand, creating a new integrated platform to support healthcare providers across Ireland, the UK and Europe.
Synapse Medical, Cardiac Services, M3 Medical, M.E.D. Ophthalmic, M.E.D. Surgical and Macromed will now operate under the Uniphar Medtech name. The unified organisation combines commercial, clinical and technical expertise with the scale of a European platform spanning 24 markets, strengthening Uniphar Medtech’s ability to deliver integrated solutions across diagnostics, digital health, imaging, interventional care, spine, ophthalmology, surgical technologies, clinical IT and managed services.
Commenting on the launch, Brian O’Shaughnessy, Chief Commercial Officer, Uniphar Medtech, said:
“Today marks a significant milestone for our organisation that reflects the journey we have been on and the business we have become; a single connected medtech organisation with the scale, expertise and infrastructure to support healthcare providers across multiple specialties and markets.
As healthcare systems become more complex, providers are increasingly looking for integrated partners who can deliver technology, services and support across the care pathway. Ultimately, it’s about making it simpler for our customers to access the full breadth of our capabilities, so we can deliver greater value to healthcare systems and the patients they serve.”
As part of the rebrand, Uniphar Medtech is committed to delivering a seamless transition, maintaining uninterrupted service and preserving the strong partnerships built across the business remain key priorities. Existing account management, sales, technical service, clinical IT and customer support teams will remain in place, ensuring continuity of relationships, expertise and day-to-day support throughout the transition.
Glenda Hearns, Director of Operations, Uniphar Medtech, added:
“Each business brings a proud history, deep market knowledge, exceptional people and long-standing partnerships, all united by a shared commitment to improving patient care. Our responsibility is to ensure healthcare providers have access to the right technologies, expertise and support when they need it most.
Close partnership between developers, regulators, healthcare systems and commercial organisations remain essential if patients are to benefit from new medical technologies more quickly and for advances to move efficiently from approval to adoption. Bringing our capabilities together accelerates that process, working more effectively across the value chain to create greater impact for healthcare providers, our partners and, most importantly, patients.”
For more information, visit https://www.unipharmedtech.com/
